Basic Androxal Information

• INN (International Nonproprietary Name): Enclomifene, alternative spelling enclomiphene.
• Brand names available in United Kingdom: Androxal® and EnCyzix are not commercially available.
• ATC Code: No ATC code assigned.
• Forms & dosages: Investigational oral tablets, usually 12.5 mg or 25 mg.
• Manufacturers in United Kingdom: No licensed UK manufacturers are listed.
• Registration status in United Kingdom: Not approved in the UK, EU or US.
• OTC / Rx classification: Prescription-only in investigational settings; not available OTC.

Latest Research Highlights On Enclomifene

What does the evidence actually say, rather than the forum chatter?

For UK patients, the starting point is regulatory rather than promotional.

Enclomifene, also known as Androxal, has no MHRA approval, no routine NHS pathway, and no ATC code assigned.

The EMA refused marketing authorisation in 2018 for secondary hypogonadism, and that refusal still matters in 2025 because the medicine remains experimental.

In the studies that were run, the signal was fairly consistent: testosterone rose, luteinising hormone and follicle-stimulating hormone increased, and the medicine acted as a gonadotropin stimulant rather than as external testosterone replacement.

That makes enclomifene biologically interesting, but not clinically established.

Trials used oral tablets, mainly 12.5 mg or 25 mg, and published follow-up only reached six months, so long-term safety is still thin.

For a man in Manchester or Cardiff asking whether this is a real treatment, the honest answer is that there is no UK NHS routine use and no licensed pharmacy supply.

The evidence is therefore suggestive, not practice-changing, which is why medical societies do not recommend it for routine care.

Enclomifene, Androxal, EMA refusal, MHRA, secondary hypogonadism, oral tablets.

Clinical Effectiveness In The UK Setting

Can a man in the UK just swap testosterone injections for an oral tablet and expect the same result?

Not with enclomifene, because there is no established NHS treatment pathway and no legitimate online or pharmacy distribution.

The mechanism is attractive: it is the active (E)-isomer of clomiphene and stimulates endogenous testosterone via LH and FSH.

That is why some men, especially those hoping to preserve fertility, look at it as a TRT alternative.

In real UK practice, though, a GP or specialist would usually assess symptoms, blood tests and fertility goals before considering established options.

Any patient-reported improvement is anecdotal rather than NHS-endorsed.

Medical societies do not recommend enclomifene, mainly because it remains unapproved and the evidence base is narrow.

Data highlight: trials suggested a rise in endogenous testosterone and gonadotropins, while UK practice only allows assessment, referral and use of licensed treatments.

That gap between investigational promise and actual care is the key point for patients comparing fertility-preserving treatment options with standard testosterone replacement therapy.

Enclomifene, endogenous testosterone, LH and FSH, fertility-preserving treatment, NHS, TRT alternative.

What It Was Studied For

What problem was enclomifene meant to solve?

It was studied for male secondary hypogonadism and for fertility-preserving approaches in men with low testosterone.

There are no MHRA-approved uses and no licensed off-label NHS practice.

“Expanded use” is mostly a search term, not a real prescribing category in the UK.

Primary hypogonadism

The testes do not produce enough testosterone, so stimulating the brain is unlikely to help.

Secondary hypogonadism

The signal from the brain to the testes is reduced, which is where enclomifene was investigated.

Infertility

Some men want treatment that supports testosterone without suppressing sperm production.

Testosterone deficiency

A broad term for low testosterone symptoms and blood results that still needs proper medical assessment.

Enclomifene was prescription-only in investigational settings, not OTC anywhere, and not authorised in the UK, EU or US.

In the UK, men with these concerns are more likely to be seen through a GP, endocrinology or fertility service than through an internet checkout.

Secondary hypogonadism, male infertility, prescription-only, off-label, MHRA.

Composition And Brand Landscape

Why do some patients see Androxal online if it is not an approved medicine?

Because the product name still circulates even though development stopped.

Enclomifene is the INN, and enclomiphene is the alternative spelling used in some documents.

Androxal® was the intended brand, while EnCyzix was only tentative and never became active.

There are no licensed generics or branded packs in Boots, LloydsPharmacy or Superdrug.

That includes the online pharmacy market, where names may be used loosely even though no approved product exists.

Androxal, enclomifene citrate, EnCyzix, oral tablets, generic, packaging.

Contraindications And Special Precautions For United Kingdom Patients

Is this the sort of medicine that suits everyone?

No, and the safety warnings matter because the drug was never licensed for routine use.

• Hypersensitivity to enclomifene or clomifene compounds: avoid if there has been an allergic reaction before.
• Hormone-dependent cancers: do not use in breast, uterine or prostate cancer.
• Pregnancy: it is not indicated for women, and there is teratogenic risk.
• Severe hepatic or renal impairment: no dosing recommendations exist, so use is not established.
• History of thrombosis or embolism: caution is needed because clot risk matters clinically.
• Uncontrolled endocrine disorders: pituitary or ovarian disorders are a red flag.

Visual disturbance, mood change or dizziness can make driving unsafe, and that is worth remembering after a late Friday-evening order or a dose taken before work.

Alcohol can also make headache, nausea or blurred vision feel worse, even though formal food interaction data are not established.

That is why pharmacist counselling matters so much in the UK, especially when someone is considering an online purchase or a private prescription from outside the NHS.

Contraindications, visual disturbances, thrombosis, hepatic impairment, pregnancy, driving.

Dosage Guidelines From The Clinical Studies

What dose was actually studied?

There is no NHS-recommended dose because the medicine is unlicensed and not approved.

The trial range was usually 12.5 mg or 25 mg taken orally once daily for male secondary hypogonadism.

Children were not studied, elderly use is not established, and liver or kidney impairment was not studied, so avoidance is the safest position.

In trial-style guidance, a missed dose would be taken when remembered unless the next dose is due soon, and overdoses had no established antidote, only supportive care.

That is the limit of reliable dosing advice.

Dosage, 12.5 mg, 25 mg, once daily, clinical studies, unlicensed.

Interactions Overview

What can go wrong when someone mixes this with other medicines?

Interaction evidence is limited because the medicine is not approved and long-term data are sparse.

• Alcohol: may worsen headache, nausea or visual symptoms.
• Other hormone-modulating drugs: could complicate testosterone, LH or FSH effects.
• Fertility treatments: specialist review is sensible before combining therapies.
• Medicines affecting clotting risk: caution is reasonable if there is a thrombosis history.
• Unknown products from grey-market outlets: the bigger issue is authenticity, not just interaction.

There is no established antidote for overdose, so supportive care is the only described approach.

Because no legitimate pharmacy distribution exists, the source of the product is part of the safety question.

If a side effect is suspected in the UK, Yellow Card reporting remains the usual route, even though enclomifene-specific data are limited.

Interactions, alcohol, Yellow Card, adverse effects, overdose, supportive care.

Cultural Perceptions And Patient Habits In The UK

Why do men keep searching for enclomifene if it is not licensed?

Often because they are embarrassed to start with a GP, or they want a fertility-preserving option and are reading online forums first.

In the UK, many patients still prefer GP-first advice, then pharmacist reassurance, then NHS 111 or a patient portal when they are unsure.

That pattern matters because hormone-related symptoms can feel personal, and many men worry about masculinity, future fertility or being dismissed.

Online discussion can make enclomifene sound more available than it is, especially when people talk about low testosterone and oral treatment in the same thread.

The reality is that there is no public record of approval in the UK, it is not available through NHS prescription systems, and some grey-market online outlets do advertise it.

• Is there a confidential way to discuss low testosterone?
• Could fertility be affected by testosterone treatment?
• Why is an online site offering a medicine that the NHS does not list?
• Which symptoms need prompt review rather than waiting?

A careful, confidential conversation with a clinician or pharmacist usually helps more than a rushed online order.

Pharmacist counselling, NHS 111, patient portal, online forums, fertility, confidentiality.

Availability And Pricing Patterns Across The United Kingdom

Can enclomifene actually be bought in the UK today?

No.

It is not commercially available anywhere in the UK and cannot be bought as a licensed medicine from Boots, LloydsPharmacy or Superdrug.

In principle, NHS prescription pricing and private purchase are different systems, but this medicine sits outside both because it has no approval.

There is no country with active OTC status, no licensed generic or branded manufacturers globally, and unregulated online outlets may offer research chemical versions.

The main regional differences across England, Scotland, Wales and Northern Ireland are in prescription governance and access to specialist services, not in product availability.

For context, our online pharmacy is able to discuss Androxal availability without a prescription and offers discreet delivery to the United Kingdom in 5-14 days, but patients still need to be clear that unlicensed products require careful checking.

Boots, LloydsPharmacy, Superdrug, private purchase, NHS prescription, online pharmacies.

Comparable Medicines And Patient Preferences

What do UK specialists usually compare it with?

The main alternatives are clomiphene citrate, tamoxifen and testosterone replacement therapy.

Enclomifene is the active (E)-isomer of clomiphene, but clomiphene has broader real-world use.

• Clomiphene citrate: oral, familiar, and more established in fertility care.
• Tamoxifen: another SERM that may be discussed in some settings.
• TRT: direct testosterone replacement, but it can suppress fertility.

Pros and cons checklist:

Possible appeal: oral convenience and interest in preserving fertility.

Main drawback: unapproved status and lack of NHS use.

Practical issue: specialist monitoring is harder to justify when the evidence base is limited.

Typical NHS preference: established alternatives because licensing, safety data and shared-care arrangements are clearer.

For many men, that difference between theory and practice is what changes the decision.

Clomiphene citrate, Clomid, Serophene, tamoxifen, TRT, alternatives.

Common Questions From United Kingdom Patients

Is Androxal available on the NHS?

No, because it is not approved for routine UK use.

Is it approved by the MHRA or EMA?

No.

The EMA refused it in 2018, and the MHRA has no routine approval to support NHS prescribing.

Why do some online pharmacies list it?

Any marketed product is unregulated or research-only, so listings should be treated with caution.

What are the main side effects?

Headache, nausea, visual disturbance, hot flushes and mood changes are the main reported effects.

EMA, MHRA, NHS, side effects, online pharmacies, unregulated.

Guidance For Proper Use And Pharmacy Support

What should a pharmacist say to a patient who is tempted to order this?

The safest advice is straightforward.

• Verify the source before spending any money.
• Avoid grey-market products and research chemical listings.
• Discuss fertility goals with a GP or specialist before using any hormone-related medicine.
• Use NHS services for assessment rather than self-medicating.
• Store tablets at 15–30°C, protect them from moisture and keep them in the original packaging.
• Do not double doses if a dose is missed.
• Seek medical review if there is blurred vision, mood change, chest pain or other worrying symptoms.

Because enclomifene is unlicensed, the safest guidance is always to check authenticity, avoid self-treatment and use NHS patient portals for follow-up when available.

That advice is especially important if someone is comparing clomifene, tamoxifen or testosterone replacement and is trying to make a quick decision late in the evening.

Pharmacist advice, storage, NHS patient portals, missed dose, authentic medicine, self-medication.

Delivery Across United Kingdom

Final Takeaway For UK Patients

Should enclomifene be treated as a genuine UK treatment option today?

No, not yet.

The evidence is interesting, but the regulatory position is clear: the EMA refused it, the MHRA has not approved it, and there is no routine NHS use.

For men with low testosterone, fertility concerns or questions about TRT alternatives, the right next step is a proper medical assessment rather than a grey-market purchase.

A pharmacist can help check symptoms, medicine sources and practical risks, while a GP or specialist can guide the wider hormonal work-up.

That is usually a safer path than chasing an unlicensed tablet with limited long-term data.